As mentioned previously, the majority of primary ccRCC tumors are characterized by heterozygous 3p loss (leading to loss of one SETD2 allele), with subsequent mutations in the remaining SETD2 allele (leading to bi-allelic SETD2 loss) occurring in more advanced stages of the disease [79]. Here, SETD2 is linked to nonpapillary renal cell carcinoma.